© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
R&D/Clinical Trials
Evolution of Prostate Cancer Treatment Gathers Speed
April 06, 2020
Amy Butcher evaluates the current treatment options for prostate cancer and the looks to the future as clinical outcomes evolve.
COVID-19: Therapeutics Under Investigation
March 31, 2020
Janita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic.
Blood Feud Divides Europe Over Plasma Shortfalls
March 09, 2020
Pharmaceutical Executive
The collection of source plasma for new therapies igniting debate.
Improving the Link from Lab to Physician
February 19, 2020
Pharmaceutical Executive
How current barriers along the roadway between biomarker testing and drug prescribing can affect decision-making for precision medicines.
The Risks and Rewards of Expedited Review
February 09, 2020
Pharmaceutical Executive
Weighing new strategies to accelerate biomedical product development.
The Roots and Rise of Cell and Gene Therapy
February 08, 2020
Pharmaceutical Executive
Continued investment will mean new cures in a new decade.
Politics & Pricing to Shape Pharma Prospects in 2020
January 13, 2020
Pharmaceutical Executive
Challenges will mount to established models for researching, developing, and marketing new therapies.
AstraZeneca's CVRM Path
January 13, 2020
AstraZeneca's Joris Silon outlines the company's efforts in CVRM (Cardiovascular, Renal and Metabolism) and the potential impact on type-2 diabetes and chronic kidney disease of SGLT2 inhibitors such as Forxiga.
Pipeline Extra: Mastering the Microbiome
December 03, 2019
As the microbiome "moves into the mainstream," Pharm Exec looks at how industry activity in the space is heating up.